The use of belatacept in kidney transplantation
Background. Kidney transplantation efficacy is limited by immunosuppression nephrotoxicity, antibody-mediated and chronic rejection. Avoiding immunosuppression nephrotoxicity is a promising strategy to improve long term outcomes. Belatacept, a synthetic immunoglobulin which blocks CD28-B7 pathway of...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2018-09-01
|
| Reeks: | Трансплантология (Москва) |
| Onderwerpen: | |
| Online toegang: | https://www.jtransplantologiya.ru/jour/article/view/394 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|